Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02695381 · ClinicalTrials.gov registry record · Phase 3
Etodolac-lidocaine Patch in Subjects Experiencing Acute Delayed Onset Muscle Soreness
A Phase 3 study, sponsored by MEDRx USA.
- Completed
- Registry status
- Phase 3
- Development phase
- 100
- Enrollment target
NCT02695381: Completed Phase 3 study, sponsored by MEDRx USA.
NCT02695381 is a Phase 3 study that has completed, run by MEDRx USA. The registered enrollment target is 100 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (87% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02695381, a Phase 3 study, has completed, sponsored by MEDRx USA.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 100 participants
- Enrollment target
Study Summary
This study evaluate the efficacy and safety of Etodolac-lidocaine topical patch applied one time daily when compared with placebo in the treatment of acute Delayed Onset Muscle Soreness (DOMS) of the upper limbs.
Interventions
- DRUG Placebo
- DRUG Etodolac-lidocaine topical patch
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2016-03 |
| Est. Completion | 2016-09 |
| Phase | Phase 3 |
What the finished NCT02695381 record still lists
NCT02695381 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (87% lower).
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT02695381 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02695381 about?
NCT02695381 is a clinical study titled "Etodolac-lidocaine Patch in Subjects Experiencing Acute Delayed Onset Muscle Soreness". This study evaluate the efficacy and safety of Etodolac-lidocaine topical patch applied one time daily when compared with placebo in the treatment of acute Delayed Onset Muscle Soreness (DOMS) of the upper limbs.
What is the current status of trial NCT02695381?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 100 participants. The study started on 2016-03. Estimated completion is 2016-09.
What interventions are being tested in trial NCT02695381?
The interventions under investigation include: Placebo (DRUG), Etodolac-lidocaine topical patch (DRUG).
Who is sponsoring clinical trial NCT02695381?
This trial is sponsored by MEDRx USA, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02695381's enrollment target sits among peer trials
100 1681st of 2000 higher than 288 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia